abbvie glp-1 receptor agonist weight management diabetes treatments agonists GLP-1 Agonists: Revolutionizing the Treatment of New Developments in Pharmacological Treatment

From the outside, that can make these medications seem simple

The GHR-R antagonist JMV 2959 neither induces malaise nor alters the malaise property of LiCl in the adult male rat

GLP-1 Examples A 2023 update 6 tells us there are currently seven GLP-1 receptor agonists, including: Exenatide Brand name: Byetta Dosage: twice-daily injection Exenatide extended-release Brand name: Bydureon Dosage: once-weekly injection Lixisenatide Brand name: Adlyxin Dosage: once-daily injection Liraglutide Brand names: Victoza and Saxenda Dosage: once-daily injection Dulaglutide Brand names: Trulicity Dosage: once-weekly injection Semaglutide Brand names: Ozempic and Wegovy Dosage: once-weekly injection Oral semaglutide Brand name: Rybelsus Dosage: once-daily injection We also can't overlook tirzepatide (branded as Mounjaro), which is the first agonist that targets both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors

Studies have shown that GLP-1 receptor agonists are effective for preventing or managing obesity

Insulin promotes glucose uptake into cells, including fat cells, and the improved metabolic control often leads to increased caloric storage

2023;6(5):e2314493